Stock MSCL SATELLOS BIOSCIENCE INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Satellos Bioscience Inc.

Equities

MSCL

CA80401L3083

Market Closed - Toronto S.E.
Other stock markets
 03:49:26 2024-06-14 pm EDT 		5-day change 1st Jan Change
0.54 CAD -6.90% Intraday chart for Satellos Bioscience Inc. -8.47% +25.58%
May. 28 Satellos Bioscience Forms Advisory Board to Advance SAT-3247 in Duchenne Muscular Dystrophy Treatment MT
May. 28 Satellos Bioscience Inc. Brief: Announcing Formation of Clinical Advisory Board to Support Advancing SAT-3247 in Clinical Trial Development for Duchenne Muscular Dystrophy MT
dc47d8b2dfec5.7Pxu777P1Lt5b1ZRyUcZXjrsyOXIvyCzzuvgVRxmf6Y.lbQ7ju2YoOw0VxthoglcbFy_jq-f0XDh45uMOEoOPPbbuDi10vzs7RRYMQ~6e52fbaadef5e12458baf94a1b396219
  1. Stock Market
  2. Equities
  3. MSCL Stock
  4. Charts Satellos Bioscience Inc.
  5. News Chart